BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3894881)

  • 1. Platelet-activating factor isolation, identification, and assay.
    Hanahan DJ; Weintraub ST
    Methods Biochem Anal; 1985; 31():195-219. PubMed ID: 3894881
    [No Abstract]   [Full Text] [Related]  

  • 2. Platelet-activating factor.
    Wykle RL; O'Flaherty JT; Thomas MJ
    Methods Enzymol; 1988; 163():44-54. PubMed ID: 3237085
    [No Abstract]   [Full Text] [Related]  

  • 3. Structural identification of platelet activating factor in psoriatic scale.
    Mallet AI; Cunningham FM
    Biochem Biophys Res Commun; 1985 Jan; 126(1):192-8. PubMed ID: 3970690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet activating factor and lyso-phosphatidylcholines from strawberry.
    Calligerou M; Siafaka-Kapadai A; Galanopoulou D; Weintraub ST; Mavri-Vavayanni M
    Phytochemistry; 1996 Jan; 41(1):89-92. PubMed ID: 8588879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-performance liquid chromatographic analysis of platelet activating factor on a cation-exchange column by direct ultraviolet detection.
    Andrikopoulos NK; Demopoulos CA; Siafaka-Kapadai A
    J Chromatogr; 1986 Aug; 363(2):412-7. PubMed ID: 3771693
    [No Abstract]   [Full Text] [Related]  

  • 6. Isolation and identification of embryo-derived platelet-activating factor in mice.
    Kodama H; Muto H; Maki M
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Jul; 41(7):899-906. PubMed ID: 2794622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Synthesis and biologic activity of some stable structure analogs of platelet activating factor].
    Kertscher HP; Ostermann G; Lang A; Weissflog W; Gawrisch K
    Pharmazie; 1985 Oct; 40(10):702-4. PubMed ID: 4080785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thin-layer and high-performance liquid chromatographic separation of glycerolipid subclasses as benzoates. Derivatives of ether and ester analogues of phosphatidylcholine, phosphatidylethanolamine and platelet activating factor.
    Blank ML; Cress EA; Fitzgerald V; Snyder F
    J Chromatogr; 1990 Jun; 508(2):382-5. PubMed ID: 2370284
    [No Abstract]   [Full Text] [Related]  

  • 9. Solid-phase extraction and reversed-phase high-performance liquid chromatographic technique for isolation and estimation of platelet activating factor in plasma.
    Salari H
    J Chromatogr; 1986 Oct; 382():89-98. PubMed ID: 3782417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved high-performance liquid chromatographic method for isolation of platelet-activating factor from other phospholipids.
    Blank ML; Snyder F
    J Chromatogr; 1983 Apr; 273(2):415-20. PubMed ID: 6863454
    [No Abstract]   [Full Text] [Related]  

  • 11. Mass spectrometric evidence for the presence of platelet-activating factor (1-0-alkyl-2-acetyl-sn-glycero-3-phosphocholine) in human amniotic fluid during labor.
    Nishihira J; Ishibashi T; Imai Y; Muramatsu T
    Lipids; 1984 Dec; 19(12):907-10. PubMed ID: 6527609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occurrence of glyceryl ethers in the phosphatidylcholine fraction of surfactant from dog lungs.
    Kumar R; King RJ; Hanahan DJ
    Biochim Biophys Acta; 1985 Aug; 836(1):19-26. PubMed ID: 3839684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitation of platelet-activating factor in biological samples using liquid chromatography/mass spectrometry with column-switching technique.
    Oda Y; Mano N; Asakawa N
    Anal Biochem; 1995 Oct; 231(1):141-50. PubMed ID: 8678293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Synthesis of phosphono analogs of 2-O-acetyl-1-O-hexadecyl(octadecyl)-sn-3-glycerylphosphorylcholine (platelet-activating factor)].
    Disselnkötter H; Lieb F; Oediger H; Wendisch D
    Arch Pharm (Weinheim); 1985 Aug; 318(8):695-700. PubMed ID: 4051690
    [No Abstract]   [Full Text] [Related]  

  • 15. Simple and rapid measurement of platelet-activating factor (PAF) in whole blood.
    Ou M; Kawasaki T; Sakon M; Kambayashi J; Siba E; Yokota M; Shinozaki K; Mori T
    Biochem Int; 1991 Jul; 24(5):823-31. PubMed ID: 1776951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific binding of antibodies to platelet-activating factor (PAF) as demonstrated by thin-layer chromatography/immunostaining.
    Karasawa K; Satoh N; Hongo T; Nakagawa Y; Setaka M; Nojima S
    Lipids; 1991 Dec; 26(12):1122-5. PubMed ID: 1819697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in the acyl composition of the platelet-activating factor (PAF) precursor and other choline phosphoglycerides of the rabbit retinal rod outer segments and neural retina.
    Bazan HE; Hurst JS; Bazan NG
    Curr Eye Res; 1994 Jan; 13(1):45-50. PubMed ID: 8156825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of lyso-platelet activating factor by negative ion gas chromatography/mass spectrometry of the nitrobenzal acetal derivatives.
    Mallet AI
    Biomed Environ Mass Spectrom; 1988 Oct; 16(1-12):207-10. PubMed ID: 3242671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological activity of lipids of pine pollen on platelet aggregation in correlation with the platelet activating factor.
    Siafaka-Kapadai A; Demopoulos CA; Andrikopoulos NK
    Biochem Int; 1986 Jan; 12(1):33-41. PubMed ID: 3947373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of platelet-activating factor and alkyl-ether phospholipids by gas chromatography-mass spectrometry via direct derivatization.
    Balazy M; Braquet P; Bazan NG
    Anal Biochem; 1991 Jul; 196(1):1-10. PubMed ID: 1888023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.